News

News

Dr. Petra Popovics (Scientist I/K01 Scholar) in Dr. William Ricke’s laboratory and collaborators at University of Miami demonstrate the potential use for GHRH antagonists for clinical therapy of human cancers and other diseases

 In a new publication in Peptides, Dr. Petra Popovics (Scientist I/K01 Scholar in Dr. William Ricke’s laboratory) and colleagues at the University of Miami, demonstrate the potential use of GHRH antagonists for clinical therapy of …

New publication by Hannah Miles (Pharmaceutical Sciences PhD student in the laboratories of Drs. William Ricke and Lingjun Li) and colleagues demonstrates a mechanistic link between aberrant intracellular citrate/acetyl coenzyme A flux and the development of an autistic-like phenotype in mice

In a new publication in Brain Communications, Hannah Miles (Pharmaceutical Sciences PhD candidate in the laboratories of Drs. William Ricke & Lingjun Li) and collaborators demonstrate a mechanistic link between aberrant intracellular citrate/acetyl coenzyme A …

Dr. Jill Macoska, UW O’Brien Center Project 3 PI, awarded NCI grant renewal for “The University of Massachusetts, Boston – Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research”

Congratulations to Dr. Jill Macoska, UW O’Brien Center Project 3 PI, Alton J. Brann Endowed Chair, Distinguished University Professor of Science and Mathematics, Director-Center for Personalized Cancer Therapy, Professor of Biological Sciences, at the University of …